Innova Exits
2023
Antibody Analytics
After supporting and investing in the business during the initial years the company bought back shares at a good multiple during a re-financing round
2021
Crucible Medtech
After supporting the company to get established the management team undertook a management buy-out of shareholders in 2021
Luperacus
Established as an antibody cancer business with unique molecules the business was acquired by Abbio in 2021
Vitamica
Set up as a spin-out from the University of Bristol the company sold its assets to a privately held business in 2021
2020
Expedeon
Acquired by Abcam in 2019 for Euro 120 million
2018
Imhanz
Acquired by Mohn Aqua Group in 2018
2017
Innova Biosciences
Acquired by Expedeon in 2017 for Euro 15 million
